167 related articles for article (PubMed ID: 25609072)
1. Knockdown of telomeric repeat binding factor 2 enhances tumor radiosensitivity regardless of telomerase status.
Yang X; Li Z; Yang L; Lei H; Yu H; Liao Z; Zhou F; Xie C; Zhou Y
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1545-52. PubMed ID: 25609072
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Ku80 correlates with radiosensitivity and telomere shortening in the U2OS telomerase-negative osteosarcoma cell line.
Hu L; Wu QQ; Wang WB; Jiang HG; Yang L; Liu Y; Yu HJ; Xie CH; Zhou YF; Zhou FX
Asian Pac J Cancer Prev; 2013; 14(2):795-9. PubMed ID: 23621240
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells.
Ke S; Zhou F; Yang H; Wei Y; Gong J; Mei Z; Wu L; Yu H; Zhou Y
Int J Oncol; 2015 Mar; 46(3):1051-8. PubMed ID: 25501936
[TBL] [Abstract][Full Text] [Related]
4. Partial knockdown of TRF2 increase radiosensitivity of human mesenchymal stem cells.
Orun O; Tiber PM; Serakinci N
Int J Biol Macromol; 2016 Sep; 90():53-8. PubMed ID: 26598048
[TBL] [Abstract][Full Text] [Related]
5. Suppression of telomere-binding protein TPP1 resulted in telomere dysfunction and enhanced radiation sensitivity in telomerase-negative osteosarcoma cell line.
Qiang W; Wu Q; Zhou F; Xie C; Wu C; Zhou Y
Biochem Biophys Res Commun; 2014 Mar; 445(2):363-8. PubMed ID: 24513288
[TBL] [Abstract][Full Text] [Related]
6. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Hsu CP; Ko JL; Shai SE; Lee LW
Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
[TBL] [Abstract][Full Text] [Related]
7. DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
Khadka P; Lee JH; Baek SH; Oh SY; Chung IK
Biochem J; 2014 Oct; 463(1):19-30. PubMed ID: 25012820
[TBL] [Abstract][Full Text] [Related]
8. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis.
Blanco R; Muñoz P; Flores JM; Klatt P; Blasco MA
Genes Dev; 2007 Jan; 21(2):206-20. PubMed ID: 17234886
[TBL] [Abstract][Full Text] [Related]
9. Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA.
Stagno D'Alcontres M; Mendez-Bermudez A; Foxon JL; Royle NJ; Salomoni P
J Cell Biol; 2007 Dec; 179(5):855-67. PubMed ID: 18056407
[TBL] [Abstract][Full Text] [Related]
10. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
11. Noncoding telomeric repeat-containing RNA inhibits the progression of hepatocellular carcinoma by regulating telomerase-mediated telomere length.
Cao H; Zhai Y; Ji X; Wang Y; Zhao J; Xing J; An J; Ren T
Cancer Sci; 2020 Aug; 111(8):2789-2802. PubMed ID: 32357278
[TBL] [Abstract][Full Text] [Related]
12. [Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells].
Xiao CY; Zhou FX; Liu SQ; Xie CH; Dai J; Zhou YF
Ai Zheng; 2005 Jun; 24(6):653-6. PubMed ID: 15946472
[TBL] [Abstract][Full Text] [Related]
13. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
[TBL] [Abstract][Full Text] [Related]
14. Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines.
French JD; Dunn J; Smart CE; Manning N; Brown MA
Genes Chromosomes Cancer; 2006 Mar; 45(3):277-89. PubMed ID: 16283620
[TBL] [Abstract][Full Text] [Related]
15. Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells.
Xu Y; Wang X; Chen SM; Chen C; Wang Y; Xiao BK; Tao ZZ
Am J Otolaryngol; 2016; 37(6):552-558. PubMed ID: 27726944
[TBL] [Abstract][Full Text] [Related]
16. Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2.
Zhang Y; Zeng D; Cao J; Wang M; Shu B; Kuang G; Ou TM; Tan JH; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3246-3256. PubMed ID: 28943299
[TBL] [Abstract][Full Text] [Related]
17. Role of the TRF2 telomeric protein in cancer and ageing.
Muñoz P; Blanco R; Blasco MA
Cell Cycle; 2006 Apr; 5(7):718-21. PubMed ID: 16582635
[TBL] [Abstract][Full Text] [Related]
18. Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer.
Frías C; García-Aranda C; De Juan C; Morán A; Ortega P; Gómez A; Hernando F; López-Asenjo JA; Torres AJ; Benito M; Iniesta P
Lung Cancer; 2008 Jun; 60(3):416-25. PubMed ID: 18077053
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of TRF2 induce telomeric ultrafine anaphase bridges and rapid telomere deletions.
Nera B; Huang HS; Lai T; Xu L
Nat Commun; 2015 Dec; 6():10132. PubMed ID: 26640040
[TBL] [Abstract][Full Text] [Related]
20. The telomeric protein TRF2 is critical for the protection of A549 cells from both telomere erosion and DNA double-strand breaks driven by salvicine.
Zhang YW; Zhang ZX; Miao ZH; Ding J
Mol Pharmacol; 2008 Mar; 73(3):824-32. PubMed ID: 18025071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
